N. Iida et al., SUPPRESSION OF ARACHIDONIC-ACID CASCADE-MEDIATED APOPTOSIS IN AFLATOXIN B-1-INDUCED RAT HEPATOMA-CELLS BY GLUCOCORTICOIDS, Carcinogenesis (New York. Print), 19(7), 1998, pp. 1191-1202
It has been shown that hypophysectomy protects aflatoxin B-1 (AFB(1))
hepatocarcinogenesis and the prevention of apoptosis is a critical pro
cess for tumorigenesis. In this paper, we analyzed the cell death of A
FB(1)-induced rat hepatoma Kagura-2 (K2) cells elicited by an estrogen
antagonist, tamoxifen (TAM), and transforming growth factor-beta 1 (T
GF-beta 1) to elucidate the function of endocrine factors in AFB(1) he
patocarcinogenesis. TAM and TGF-beta 1 induced a typical apoptosis in
K2 cells, The apoptotic cell death was efficiently suppressed by gluco
corticoids (GCs), but not by other steroid compounds including 17 beta
-estradiol (E-2), Cyclo-oxygenase (COX) inhibitors such as aspirin (AS
P) and indomethacin (IND) also inhibited the apoptosis, while inhibito
ry effects of general lipoxygenase (LOX) inhibitors such as nordihydro
guaiaretic acid (NDGA) and 5,8,11-eicosatrienoic acid (ETI) were not o
bserved, TAM and TGF-beta 1 enhanced the release of [H-3]arachidonic a
cid (AA) from pre-labeled K2 cells, which was inhibited by dexamethaso
ne (DEX), Furthermore, cytosolic phospholipase A(2) (cPLA(2)) activity
in K2 cells treated with TAM for 2 h was higher than that in the cont
rol. Prostaglandin J(2) (PGJ(2)) and Delta(12)-PGJ(2), AA metabolites
formed in the COX pathway, induced K2 cell death, These results sugges
t that AA metabolites are involved in apoptotic K2 cell death elicited
by TAM and TGF-beta(1), and GCs could act as a tumor promoter in AFB(
1) hepatocarcinogenesis through the prevention of apoptosis induced by
AA metabolites formed in vivo.